Identification of Protective Anti-HCV Antibodies in Subjects that Clear Infection to Inform Vaccine Design

Back to search results

Our goal is to understand immune responses to hepatitis C virus and design new vaccines that provoke robust innate and adaptive immune responses to the virus without immune escape. This is an unmet need for a disease that affects over 80 million people globally but with limited and prohibitively expensive treatment options. Our team is highly interdisciplinary with a broad expertise. Clinically, we undertake prospective studies and clinical trials related to hepatitis C infection in prisons. These studies ensure collection of unique clinical samples. Our laboratories apply inter-disciplinary methods that include state-of-the-art molecular, proteomics and cell biology approaches to identify key immune determinants that result in favorable clinical outcome during hepatitis C infection. To this end, we have a unique cohort of patients that are highly resistant to hepatitis C infection, despite high risk exposure. We will characterise their efficient immunity to the virus to inform us in developing vaccines that trigger effective protective immunity.

Apply Now
Supervisory team
Nicodemus
Tedla

Medicine
Medical Sciences
Auda
Eltahla

Medicine
Medical Sciences
Rowena
Bull

Medicine
Medical Sciences
n.tedla@unsw.edu.au

Apply Now

Please start your application by taking the self assessment. Download the editable MS Word version or download the non-editable PDF version (best for Mac or mobile devices). Once the self assessment form is completed, save as a PDF and upload along with your application.

One file only.
50 MB limit.
Allowed types: gif jpg png bmp eps tif pict psd txt rtf html odf pdf doc docx ppt pptx xls xlsx xml avi mov mp3 ogg wav bz2 dmg gz jar rar sit svg tar zip.
If you have not done so, please complete the self assessment PDF as noted above.